Economic uncertainty has raised concerns across multiple industries, and pharmaceutical companies are no exception. While some businesses struggle during a downturn, experts believe the pharma sector remains more resistant than others. Factors such as long product life cycles, patent protections, and strong cash flow provide stability. However, challenges like rising costs, supply chain issues, and workforce concerns could still create setbacks. Recession Fears and Economic Warning Signs The stock market has shown signs of distress, with trade tensions,...